Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Irritable Bowel Syndrome

  Free Subscription


4 Aliment Pharmacol Ther
1 Aust N Z J Obstet Gynaecol
1 BMJ Open Gastroenterol
1 Clin Gastroenterol Hepatol
1 Clin Pharmacol Drug Dev
1 Crit Rev Microbiol
1 Curr Gastroenterol Rep
1 Curr Mol Med
2 Front Med (Lausanne)
1 Front Nutr
1 Gastroenterology
1 Gut Microbes
2 Int J Mol Sci
1 J Clin Med
1 J Gastroenterol Hepatol
1 Medicine (Baltimore)
1 Nat Rev Gastroenterol Hepatol
1 Neurogastroenterol Motil
1 Turk J Gastroenterol
1 United European Gastroenterol J

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
    Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Aug 9. doi: 10.1111/apt.17179.
    PubMed         Abstract available

  2. CASTRO TEJERA V, Ohman L, Aabakken L, Fellstrom B, et al
    Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-Effects on gastrointestinal symptoms and rectal biomarkers of immune activity.
    Aliment Pharmacol Ther. 2022 Aug 8. doi: 10.1111/apt.17182.
    PubMed         Abstract available

  3. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.
    Aliment Pharmacol Ther. 2022;56:894-895.

  4. SHAH ED, Wechsler EV
    Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022;56:892-893.

    Aust N Z J Obstet Gynaecol

  5. RYAN A, Healey M, Cheng C, Dior U, et al
    Central sensitisation in pelvic pain: A cohort study.
    Aust N Z J Obstet Gynaecol. 2022 Aug 11. doi: 10.1111/ajo.13596.
    PubMed         Abstract available

    BMJ Open Gastroenterol

  6. KOVACS DB, Szekely A, Hubai AG, Palsson O, et al
    Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar.
    BMJ Open Gastroenterol. 2022;9.
    PubMed         Abstract available

    Clin Gastroenterol Hepatol

  7. CHAN WW, Grover M
    The COVID-19 Pandemic and Postinfection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists.
    Clin Gastroenterol Hepatol. 2022 Aug 6. pii: S1542-3565(22)00601.

    Clin Pharmacol Drug Dev

  8. BOINPALLY R, McGeeney D, Kaczynski E, Weissman D, et al
    An Open-Label Study to Evaluate the Effect of Eluxadoline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Participants.
    Clin Pharmacol Drug Dev. 2022 Aug 8. doi: 10.1002/cpdd.1150.
    PubMed         Abstract available

    Crit Rev Microbiol

    Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917.
    Crit Rev Microbiol. 2022 Aug 10:1-17. doi: 10.1080/1040841X.2022.2109405.
    PubMed         Abstract available

    Curr Gastroenterol Rep

  10. MA W, Drew DA, Staller K
    The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.
    Curr Gastroenterol Rep. 2022 Aug 9. pii: 10.1007/s11894-022-00847.
    PubMed         Abstract available

    Curr Mol Med

  11. XU R, Liu X, Tian M, Chen D, et al
    Atractylodes-I overcomes the oxidative stress-induced colonic mucosal epithelial cells dysfunction to prevent irritable bowel syndrome via modulating the miR-34a-5p-LDHA signaling pathway.
    Curr Mol Med. 2022 Aug 11. pii: CMM-EPUB-125439.
    PubMed         Abstract available

    Front Med (Lausanne)

  12. NABI MY, Nauhria S, Reel M, Londono S, et al
    Endometriosis and irritable bowel syndrome: A systematic review and meta-analyses.
    Front Med (Lausanne). 2022;9:914356.
    PubMed         Abstract available

  13. ZHENG Z, Tang J, Hu Y, Zhang W, et al
    Role of gut microbiota-derived signals in the regulation of gastrointestinal motility.
    Front Med (Lausanne). 2022;9:961703.
    PubMed         Abstract available

    Front Nutr

  14. BILAL M, Ashraf S, Zhao X
    Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics.
    Front Nutr. 2022;9:931458.
    PubMed         Abstract available


  15. GRABAUSKAS G, Gao J, Wu X, Zhou SY, et al
    Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.
    Gastroenterology. 2022 Aug 4. pii: S0016-5085(22)00829.
    PubMed         Abstract available

    Gut Microbes

  16. NABAVI-RAD A, Sadeghi A, Asadzadeh Aghdaei H, Yadegar A, et al
    The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management.
    Gut Microbes. 2022;14:2108655.
    PubMed         Abstract available

    Int J Mol Sci

  17. KRISHNACHAITANYA SS, Liu M, Fujise K, Li Q, et al
    MicroRNAs in Inflammatory Bowel Disease and Its Complications.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available

  18. MEADE E, Garvey M
    The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available

    J Clin Med

  19. MATTILA J, Stenholm T, Loyttyniemi E, Koffert J, et al
    Predictive Markers of Crohn's Disease in Small Bowel Capsule Endoscopy: A Retrospective Study of Small Bowel Capsule Endoscopy.
    J Clin Med. 2022;11.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  20. LI X, Ren K, Hong X, Guo S, et al
    Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
    PubMed         Abstract available

    Medicine (Baltimore)

  21. KIM JH, Yi DY, Lee YM, Choi YJ, et al
    Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome.
    Medicine (Baltimore). 2022;101:e29968.
    PubMed         Abstract available

    Nat Rev Gastroenterol Hepatol

  22. CAMILLERI M, Zhernakova A, Bozzarelli I, D'Amato M, et al
    Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.
    Nat Rev Gastroenterol Hepatol. 2022 Aug 10. pii: 10.1038/s41575-022-00662.
    PubMed         Abstract available

    Neurogastroenterol Motil

  23. ZHOU Q, Verne GN
    Epigenetic modulation of visceral nociception.
    Neurogastroenterol Motil. 2022 Aug 10:e14443. doi: 10.1111/nmo.14443.
    PubMed         Abstract available

    Turk J Gastroenterol

  24. DEMIROREN K, Guney B, Bostanci M, Ekici D, et al
    A Comparison Between Rome III and Rome IV Criteria in Children with Chronic Abdominal Pain: A Prospective Observational Cohort Study.
    Turk J Gastroenterol. 2022 Aug 10. doi: 10.5152/tjg.2022.21893.
    PubMed         Abstract available

    United European Gastroenterol J

  25. BISCHOFF SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, et al
    European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.
    United European Gastroenterol J. 2022 Aug 12. doi: 10.1002/ueg2.12280.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.